These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4602058)

  • 61. [The Rorschach test in parkinsonian patients. Its course during treatment with L dopa. Its prognostic value].
    Sevilla M; Vernet JP; Becle J; Darcourt G
    Ann Med Psychol (Paris); 1973 May; 1(5):577-608. PubMed ID: 4761931
    [No Abstract]   [Full Text] [Related]  

  • 62. Abnormal mouth-movements and oral damage associated with L-DOPA treatment.
    Sacks OW; Ross SJ; DePaola DP; Kohl MS
    Ann Dent; 1970; 29(4):130-44. PubMed ID: 5275661
    [No Abstract]   [Full Text] [Related]  

  • 63. L-Dopa treatment in Parkinson's Disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969
    [No Abstract]   [Full Text] [Related]  

  • 64. [The therapeutic effect of L-dopa].
    Groneberg P; Struppler A
    Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
    [No Abstract]   [Full Text] [Related]  

  • 65. [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
    Sano I; Taniguchi K
    Munch Med Wochenschr; 1972 Oct; 114(40):1717-9. PubMed ID: 4538893
    [No Abstract]   [Full Text] [Related]  

  • 66. [Collateral effects of L-dopa treatment in patients with parkinsonism].
    Signorelli CD; D'Andrea F; De Divitiis E
    Sist Nerv; 1970; 22(2):109-14. PubMed ID: 5504548
    [No Abstract]   [Full Text] [Related]  

  • 67. [Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)].
    Gehlen W; Eisenlohr JJ
    Nervenarzt; 1974 Jan; 45(2):22-9. PubMed ID: 4601993
    [No Abstract]   [Full Text] [Related]  

  • 68. [Excitability of the spinal motor neurons in patients with Parkinsonism and athetosis treated with L-dopa].
    Messina C
    Riv Neurol; 1972; 42(3):225-31. PubMed ID: 5071006
    [No Abstract]   [Full Text] [Related]  

  • 69. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract]   [Full Text] [Related]  

  • 70. Treatment of parkinsonism with L-dopa (study of 105 patients).
    Klawans HL; Garvin JS
    Dis Nerv Syst; 1969 Nov; 30(11):737-46. PubMed ID: 5359046
    [No Abstract]   [Full Text] [Related]  

  • 71. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
    Lhermitte F; Rosa A; Comoy E; Bohuon C
    Rev Neurol (Paris); 1973 Dec; 129(6):313-24. PubMed ID: 4794176
    [No Abstract]   [Full Text] [Related]  

  • 72. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U
    Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract]   [Full Text] [Related]  

  • 73. An evaluation of L-dopa in Parkinson patients.
    Mones RJ
    Trans Am Neurol Assoc; 1969; 94():307-9. PubMed ID: 5374472
    [No Abstract]   [Full Text] [Related]  

  • 74. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R; de Ajuriaguerra J
    Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
    [No Abstract]   [Full Text] [Related]  

  • 75. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 76. [Habituation of trigemino-facial reflexes in parkinsonism treated with L-DOPA].
    Messina C
    Riv Neurol; 1970; 40(5):327-36. PubMed ID: 5507461
    [No Abstract]   [Full Text] [Related]  

  • 77. DOPA in Parkinson's disease.
    Lancet; 1969 Apr; 1(7600):871-2. PubMed ID: 4180531
    [No Abstract]   [Full Text] [Related]  

  • 78. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470
    [No Abstract]   [Full Text] [Related]  

  • 79. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Analysis of the effects of L-dopa during a 3-month course of treatment].
    Pinto F; Venturini E
    Riv Neurobiol; 1970; 16(4):415-28. PubMed ID: 4949926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.